| Source: |
| Type: |
| CardioProtective |
| Normal Healthy |
| 5353- | AL, | Aged Garlic Extract May Be Safe for Patients on Warfarin Therapy |
| - | Human, | Nor, | NA |
| 2559- | AL, | Effect of the Garlic Pill in comparison with Plavix on Platelet Aggregation and Bleeding Time |
| - | Human, | Nor, | NA |
| 3451- | ALA, | Alpha-lipoic acid ameliorates H2O2-induced human vein endothelial cells injury via suppression of inflammation and oxidative stress |
| - | in-vitro, | Nor, | HUVECs |
| 4991- | ART/DHA, | doxoR, | Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy |
| - | in-vivo, | Nor, | H9c2 |
| 5413- | ASA, | Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin |
| - | Trial, | Nor, | NA |
| 5419- | ASTX, | Astaxanthin and other Nutrients from Haematococcus pluvialis—Multifunctional Applications |
| - | Review, | Nor, | NA |
| 5445- | ATV, | Atorvastatin |
| - | NA, | Nor, | NA |
| 5248- | Ba, | BA, | doxoR, | Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | HUVECs |
| 2601- | Ba, | Cardioprotective effects of baicalein on heart failure via modulation of Ca2 + handling proteins in vivo and in vitro |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
| 2294- | Ba, | Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes |
| - | in-vivo, | Nor, | NA |
| 2696- | BBR, | Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway |
| - | in-vivo, | Nor, | NA |
| 2676- | BBR, | Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress |
| - | in-vivo, | Nor, | NA | - | in-vivo, | CardioV, | NA |
| 2684- | BBR, | Berberine is a Novel Mitochondrial Calcium Uniporter Inhibitor that Disrupts MCU‐EMRE Assembly |
| - | in-vivo, | Nor, | NA |
| 5514- | bemA, | Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients |
| - | Trial, | Nor, | NA |
| 2771- | BetA, | Cardioprotective Effect of Betulinic Acid on Myocardial Ischemia Reperfusion Injury in Rats |
| - | in-vivo, | Nor, | NA | - | in-vivo, | Stroke, | NA |
| 5708- | Brut, | Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers |
| - | Review, | Nor, | NA |
| 5872- | CA, | Nrf2/ARE-Mediated Antioxidant Actions of Pro-Electrophilic Drugs |
| - | Review, | Nor, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 5885- | CAR, | Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HEK293 |
| 5881- | CAR, | Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties |
| - | Review, | Nor, | NA |
| 5900- | CAR, | TV, | Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol |
| - | Review, | Nor, | NA |
| 5926- | CAR, | An Updated Review of Research into Carvacrol and Its Biological Activities |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | asthmatic, | NA |
| 6008- | CGA, | Risk Assessment of Chlorogenic and Isochlorogenic Acids in Coffee By-Products |
| - | Review, | Nor, | NA |
| 6011- | CGA, | Chlorogenic Acid’s Role in Metabolic Health: Mechanisms and Therapeutic Potential |
| - | Review, | Nor, | NA |
| 6087- | CHOC, | Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial |
| - | Trial, | Nor, | NA |
| 6090- | CHOC, | Cocoa Flavanol Intake and Biomarkers for Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| - | Review, | Nor, | NA |
| 6091- | CHOC, | Chocolate Consumption in Relation to All-Cause and Cause-Specific Mortality in Women: The Women's Health Initiative |
| - | Study, | Nor, | NA |
| 6084- | CHOC, | Cocoa Polyphenols and Their Potential Benefits for Human Health |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA |
| 6098- | Chol, | Choline |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 2807- | CHr, | Evidence-based mechanistic role of chrysin towards protection of cardiac hypertrophy and fibrosis in rats |
| - | in-vivo, | Nor, | NA |
| 4987- | Dipy, | ATV, | Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination |
| - | in-vivo, | Nor, | NA |
| 3231- | EGCG, | Epigallocatechin-3-gallate restores mitochondrial homeostasis impairment by inhibiting HDAC1-mediated NRF1 histone deacetylation in cardiac hypertrophy |
| - | in-vitro, | Nor, | NA |
| 5227- | EMD, | Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy |
| - | vitro+vivo, | Nor, | NA |
| 2846- | FIS, | Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity |
| - | in-vitro, | Nor, | NA |
| 2901- | HNK, | doxoR, | Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts |
| - | in-vivo, | Nor, | NA |
| 2889- | HNK, | doxoR, | Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice |
| - | in-vivo, | Nor, | NA |
| 2893- | HNK, | doxoR, | Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts |
| - | in-vivo, | Nor, | NA |
| 2926- | LT, | Luteolin ameliorates rat myocardial ischemia-reperfusion injury through peroxiredoxin II activation: LUT's cardioprotection through PRX II |
| - | in-vitro, | Nor, | H9c2 |
| 3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3263- | Lyco, | Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening |
| - | in-vitro, | Nor, | H9c2 | - | in-vitro, | Stroke, | NA |
| 4796- | Lyco, | The Anti-proliferation Effects of Lycopene on Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 |
| 4528- | MAG, | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
| - | Review, | Nor, | NA |
| 4705- | MEL, | Melatonin: beyond circadian regulation - exploring its diverse physiological roles and therapeutic potential |
| - | Review, | Nor, | NA |
| 5785- | MET, | Metformin improves healthspan and lifespan in mice |
| - | in-vivo, | Nor, | NA |
| 3467- | MF, | Pulsed Magnetic Field Induces Angiogenesis and Improves Cardiac Function of Surgically Induced Infarcted Myocardium in Sprague-Dawley Rats |
| - | in-vivo, | Nor, | NA |
| 2933- | NAD, | Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns |
| - | Review, | Nor, | NA | - | NA, | AD, | NA | - | NA, | Diabetic, | NA | - | NA, | Stroke, | NA | - | NA, | LiverDam, | NA | - | NA, | Park, | NA |
| 2042- | PB, | Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury |
| - | in-vitro, | Nor, | NA |
| 5025- | QC, | New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation |
| - | Review, | Nor, | NA |
| 3534- | QC, | Lyco, | Synergistic protection of quercetin and lycopene against oxidative stress via SIRT1-Nox4-ROS axis in HUVEC cells |
| - | in-vitro, | Nor, | HUVECs |
| 3353- | QC, | Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2/M-phase cell cycle arrest in KON oral cancer cells |
| - | in-vitro, | Oral, | KON | - | in-vitro, | Nor, | MRC-5 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1188 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid